{"@context":"https://schema.org","@type":"Article","headline":"Part 2 short accompanying notice","description":"Learn how the short 42 CFR Part 2 notice accompanies a consented disclosure and why brevity does not remove consent-copy or scope requirements.","url":"https://finnihealth.com/resources/glossary/part-2-short-accompanying-notice","datePublished":"2026-08-17T00:00:00.000Z","dateModified":"2026-08-24T00:00:00.000Z","author":{"@type":"Organization","name":"Finni Health Editorial Team"},"publisher":{"@type":"Organization","name":"Finni Health","url":"https://www.finnihealth.com"},"isPartOf":{"@type":"CollectionPage","name":"ABA and Practice Operations Glossary","url":"https://www.finnihealth.com/resources/glossary"},"breadcrumb":{"@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Resources","item":"https://www.finnihealth.com/resources"},{"@type":"ListItem","position":2,"name":"Glossary","item":"https://www.finnihealth.com/resources/glossary"},{"@type":"ListItem","position":3,"name":"Part 2 short accompanying notice","item":"https://finnihealth.com/resources/glossary/part-2-short-accompanying-notice"}]}}
Glossary term

Part 2 short accompanying notice

Learn how the short 42 CFR Part 2 notice accompanies a consented disclosure and why brevity does not remove consent-copy or scope requirements.

5
min read
Updated
August 23, 2026
Sources checked
August 23, 2026
· View sources
Also called

short Part 2 redisclosure notice SUD disclosure statement 2

A short Part 2 notice is the second written-statement option for a disclosure made with the patient's written consent. Its regulatory text is: “42 CFR part 2 prohibits unauthorized use or disclosure of these records.” A program may use this short notice instead of the detailed statement, while still supplying a copy of the consent or a clear explanation of its scope and satisfying every release gate.

Editorial approval scope: The team checked current source fidelity, scope boundaries, dates, arithmetic, reader usefulness, practical workflow, and general-information limitations.

The short statement is a complete notice option

42 CFR 2.32 permits either Statement 1 or Statement 2. The short version should use the current regulatory wording. A locally shortened paraphrase may omit the very language that makes it the permitted option.

Store the statement as controlled content with source, version, effective date, legal reviewer, language, format, and channel mapping. Lock the words against local editing, template cleanup, automatic abbreviation, or translation changes outside the approved process. Preserve the exact notice version included in each disclosure event.

The short statement is concise enough to fit many interfaces, but it still needs to be legible, accessible, and associated with the records. A tiny footer, clipped metadata field, detached cover page, or sender-side note may fail to communicate anything to the recipient.

Short notice does not mean short workflow

The program still verifies record status, consent validity, recipient, purpose, expiration, revocation, minimum appropriate content, secure delivery, and any state-law condition. The package also needs the consent copy or clear scope explanation required by the same section.

Build the release gate in independent parts: supported disclosure authority, exact record set, verified recipient and route, current short notice, consent copy or scope explanation, and delivery evidence. A pass in one part cannot cure a failure in another. The package should remain held until every required component is ready.

The statement does not authorize the recipient's later use or disclosure, decide whether HIPAA applies, eliminate proceeding restrictions, or expand the patient's consent. Route downstream questions to qualified privacy or legal review rather than treating the short wording as a blanket answer.

Choose the notice through policy

Define which delivery routes use the short statement, where it appears, how it remains associated with each record, and how recipients see it before opening or using the material. Test portals, fax cover sheets, secure email, interfaces, and exported files separately.

For paper or fax, keep the statement with the pages if a cover sheet separates. For secure email or portal delivery, confirm the recipient can access the notice and records during the same transaction. For APIs and health-information exchange, verify that the statement survives serialization, routing, storage, download, and recipient display.

Include direct messaging, batch exports, recurring feeds, vendor transfers, mobile download, print, forwarding, retry, partial failure, and downtime in route tests. Record the destination view, not only a successful sender log.

Handle missing or detached notices

Treat truncation, wrong wording, inaccessible attachment, expired link, separated page, rejected metadata, or notice-free retry as a defective package. Stop or contain the transfer where feasible, preserve evidence, correct the route, and assess earlier disclosures using the same configuration. Do not rewrite the historical event after correction.

Assign each held package an owner, next action, and review deadline.

Provide a protected recipient-support channel for questions. Staff can explain where the statement and consent-scope material appear while avoiding informal permission beyond the current disclosure.

Example with route testing

Seven approved delivery routes are tested. Six preserve the short statement with every disclosed record; one portal detaches the notice after download. Route readiness is 6 of 7 routes. The portal stays unavailable for Part 2 releases until corrected.

The owner repairs the download bundle, confirms that the short statement and scope artifact remain readable with the records, and reviews prior portal events. The original six-of-seven result stays visible while the successful regression test creates a new checkpoint.

Short-notice checklist

  • Use the current approved regulatory wording without local paraphrase.
  • Pair the notice with a consent copy or clear scope explanation.
  • Keep consent, scope, recipient, records, and route validation separate.
  • Confirm recipient-visible association across every delivery channel.
  • Test retries, forwarding, download, print, and partial failures.
  • Hold missing, stale, clipped, or detached notice packages.
  • Preserve corrections and review earlier events on the same route.

Owner controls

The 2024 final rule supports the current notice structure. Use locked wording, route-specific templates, attachment tests, consent-scope pairing, access controls, failure alerts, and retained delivery evidence.

Monitor short-notice use, active versions, complete packages, channel failures, recipient questions, corrected routes, and older templates. Audit from disclosures back to recipient-visible proof and from every configured route into current test evidence. Retest after regulatory, consent, interface, vendor, accessibility, or translation changes.

Related terms

Sources

Beyond the glossary

Take the next step with clarity

Whether you are finding care, growing as a clinician, or building a stronger ABA practice, Finni brings the people, tools, and support together to help you move forward.

Start or grow your ABA practice with Finni